Cargando…
Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
BACKGROUND: Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) portends a worse prognosis. The objective of this study was to compare the efficacy of percutaneous radiofrequency ablation (RFA) combined with transarterial chemoembolization (TACE) plus sorafenib to that of the mos...
Autores principales: | Ding, Xiaoyan, Sun, Wei, Chen, Jinglong, Li, Wei, Shen, Yanjun, Guo, Xiaodi, Teng, Ying, Liu, Xiaomin, Sun, Shasha, Wei, Jianying, Li, Wendong, Chen, Hui, Liu, Bozhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644860/ https://www.ncbi.nlm.nih.gov/pubmed/33194699 http://dx.doi.org/10.3389/fonc.2020.578633 |
Ejemplares similares
-
Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy
por: Zhang, Lei, et al.
Publicado: (2020) -
A Retrospective Study on Therapeutic Efficacy of Transarterial
Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in
Patients With Unresectable Hepatocellular Carcinoma
por: Teng, Ying, et al.
Publicado: (2022) -
Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014) -
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020) -
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)